back to homepage

World News

Alkermes Gets FDA Approval for Schizophrenia Treatment Aristada

Alkermes Gets FDA Approval for Schizophrenia Treatment Aristada

Alkermes (ALKS), a biopharmaceutical company, said Tuesday the U.S. Food and Drug Administration has approved ARISTADA extended-release injectable suspension to treat schizophrenia. The company is preparing to launch the drug

Read More
Biomed Realty Trust Exploring Sale

Biomed Realty Trust Exploring Sale

Biomed Realty Trust (BMR) is trading more than 9% higher in pre-market in reaction to a report from Bloomberg that the company is exploring a sale, and has retained Morgan

Read More
GE Healthcare Commits $300 Mln to Create New Business Unit

GE Healthcare Commits $300 Mln to Create New Business Unit

GE Healthcare, the healthcare technology division of GE (GE), said it has created a new business unit, Sustainable Healthcare Solutions, that will develop high-value, low-cost technologies and healthcare delivery solutions

Read More